Spc. Dr. Hüseyin Sancar Bozkurt

Spc. Dr. Hüseyin Sancar Bozkurt

Gastroenterology

Personal Info

figure

Emergency Cases

+90 216 585 32 00

Spc. Dr. Hüseyin Sancar Bozkurt

Education:

Year Degree Institute
2003 Trakya University Faculty of Medicine
2009 Internal Medicine Specialization Cukurova University Faculty of Medicine
2021 Gastroenterology Adana Baskent University
Assistant Professor Istanbul Maltepe University Gastroenterology Clinic

Experience:

Year Department Position Hospital
2009 Elazig Kovancilar State Hospital
2009 - 2012 Başkent University Adana Application and Research Center
2012 - 2014 Kahramanmaraş Necip Fazıl City Hospital
2014 - 2015 Private Defne Hospital
2015-2025 Private Tarsus Medical Park Hospital
2025-Currently Private Pendik Bolge Hospital

MEDICAL INTERESTS

  • Endoscopy
  • Colonoscopy
  • Dysbiosis (Gut Microbiota Imbalance)
  • Inflammatory Bowel Diseases (Ulcerative Colitis, Crohn’s Disease, Celiac Disease)
  • IBS (Irritable Bowel Syndrome)
  • SIBO (Small Intestinal Bacterial Overgrowth)
  • Leaky Gut Syndrome
  • Gut-Related Autoimmune Disorders (Hashimoto’s, Diabetes Mellitus, Allergy, Urticaria, Eczema, Asthma, Pancreatic Disorders)
  • Functional Diarrhea
  • Functional Constipation
  • Intestinal Diverticula
  • Probiotics

    • PUBLICATIONS

  • Hazan S, Stollman N, Bozkurt HS, et al. Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity. BMJ Open Gastroenterology, 2022;9:e000871. doi: 10.1136/bmjgast-2022-000871
  • Hüseyin Sancar Bozkurt, Hülya Civelek Yörüklü, Kutsal Bozkurt, Cenk Denktaş, Altan Bozdoğan, Orhan Özdemir, Bestami Özkaya. Biodegradation of microplastic by probiotic Bifidobacterium. International Journal of Global Warming (IJGW), Vol. 26, No. 4, 2022.
  • Denktaş C, Baysoy DY, Bozdoğan A, Bozkurt HS, Bozkurt K, Özdemir O, Yılmaz M. Development and characterization of sodium alginate/Bifidobacterium probiotic biohybrid material used in tissue engineering. Journal of Applied Polymer Science, 2022; 139(18):52086. https://doi.org/10.1002/app.52086
  • Bozkurt HS, Bilen Ö. Oral booster probiotic Bifidobacteria in SARS-COV-2 patients. International Journal of Immunopathology and Pharmacology, 2021. https://doi.org/10.1177/20587384211059677
  • Bozkurt HS, Bilen Ö. Gastrointestinal symptoms in COVID-19 could be associated with severe lung involvement and increased readmission rates. European Journal of Inflammation, 2021. https://doi.org/10.1177/20587392211048259
  • Bozkurt HS, Quigley EM. The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis. International Journal of Immunopathology and Pharmacology, 2020. doi: 10.1177/2058738420961304
  • Bozkurt HS, Kara B. A new treatment for ulcerative colitis: Intracolonic Bifidobacterium and xyloglucan application. European Journal of Inflammation, 2020. doi: 10.1177/2058739220942626
  • Bozkurt C, Denktaş C, Özdemir O, Altındal A, Avdan Z, Bozkurt HS. Charge transport in Bifidobacterium animalis subsp. lactis BB-12 under various atmospheres. Open Journal of Applied Sciences (OJAPPS), 2019. doi: 10.4236/ojapps.2019.96040
  • Hüseyin Sancar Bozkurt, Eamonn MM Quigley. Bifidobacteria and mucosal-associated invariant T (MAIT) cells: A new approach to colorectal cancer prevention? Gastrointestinal Disorders, 2019, 1(2):266–272. https://doi.org/10.3390/gidisord1020022
  • Hüseyin Sancar Bozkurt, Banu Kara. Combination of oral vancomycin and intra-colonic vancomycin: Successful treatment of complicated pseudomembranous colitis in a child patient. SAGE Open Medical Case Reports, 2019;7. doi: 10.1177/2050313X19838442
  • Bozkurt HS, Quigley EM, Kara B. Bifidobacterium animalis subspecies lactis engineered to produce mycosporin-like amino acids in colorectal cancer prevention. Science of Microorganisms (SOM), 2019; 7:1–5
  • Hüseyin Sancar Bozkurt, Banu Kara. Can fortified Bifidobacterium with mycosporin-like amino acid be a new insight for neurological diseases’ treatment? Autism – Open Access, 2017; 7:5. doi: 10.4172/2165-7890.1000219
  • Bozkurt HS, Kara B. Bifidobacterium and mycosporin-like amino acid cooperation: A new era for intestinal diseases treatment? Journal of Gastric Disorders & Therapy, 2017; 3(2).

    • AWARDS

    1. American Gastroenterological Association – Clinician’s Recommendation Award (2017)
    2. American Gastroenterological Association – Top Contributor Recognition Award (2017)
    3. United European Gastroenterology – Basic Science Award (2018): “Bifidobacterium animalis subsp. lactis engineered to produce mycosporin-like amino acids in colorectal cancer prevention.” UEG Week 2018, October 20–24, Vienna, Austria
    4. Microbiome from Mother to Child Symposium – US Scholarship Award (2021): “Harnessing the Microbiome for Disease Prevention and Therapy” joint symposium with “The Microbiome: From Mother to Child” Organizers: Eric G. Pamer, Laurie E. Comstock, Alan Walker. Date: January 17–21, 2021 (Virtual meeting)
    5. Best Study and Presentation Award for Single-Strain Probiotic Therapy in COVID-19 (2021): Korean Gastroenterology Week, KGFID Award at KDDW 2021
    6. Sigma Xi Scientific Research Honor Society – Full Membership Award (2024): Full Member of Sigma Xi, The Scientific Research Honor Society
    7. American Gastroenterological Association – AGA Fellow Award (2025)